NCT00279344View on ClinicalTrials.gov

Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

August 31, 2007

Conditions
Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain.
Interventions
DRUG

Fentanyl (Matrifen)

Sponsors

Lead Sponsor

Nycomed
All Listed Sponsors
lead

Nycomed

INDUSTRY